TABLE 1.

Prevalence of the HBV reverse transcriptase polymorphisms in MALDI-TOF MS assay in selected patients

Patient no.	Analyzed HBV reverse transcriptase polymorphisms (allele %)
	L80I(V)	I169T	V173L	L180M	A181T(V)	T184G	A194T	S202I	M204V(I)	I233V	N236T	M250V
23	V (4)	WTa	L (3)	WT	T (2)	WT	WT	WT	I (30)	V (10)	WT	V (4)
28	I (2)	WT	L (4)	M (13)	WT	WT	WT	WT	V (16)	V (11)	WT	V (3)
69III	WT	WT	L (1)	WT	WT	WT	WT	WT	WT	WT	T (7)	WT
95	WT	T (11)	WT	M (29)	WT	G (5)	WT	WT	V (6)	V (4)	WT	V (5)
97	I (3)	WT	L (4)	WT	V (3)	WT	WT	WT	I (5)	WT	V (4)	(8)
115	WT	WT	WT	WT	WT	WT	WT	WT	WT	WT	T (3)	WT
118IV	I (13)	WT	L (3)	M (12)	T (2)	WT	G (17)	WT	I (21)	V (2)	WT	V (6)
123	I (1)	WT	L (2)	M (48)	WT	WT	WT	WT	V (31)	V (3)	WT	V (4)
139	I (2)	WT	WT	WT	WT	WT	WT	WT	WT	WT	WT	WT
144	WT	WT	WT	WT	WT	WT	WT	WT	WT	WT	WT	WT

^aWT, wild type of HBV.